translate
es
arrow_drop_down
translate
es
arrow_drop_down
gl
en
Identifícate
Portal de la
INVESTIGACIÓN
Grupos
Investigadores/as
Resultados
Victor
Del Campo Pérez
GlaxoSmithKline (United Kingdom)
Londres, Reino Unido
Estás en
Colaboraciones
GlaxoSmithKline (United Kingdom)
Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (1)
2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study
eClinicalMedicine, Vol. 62